Aclarion EBIT Margin 2021-2025 | ACON

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Aclarion ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Aclarion ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$147.1B
CVS Health (CVS)	$76.8B
Elevance Health (ELV)	$65.1B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$25.7B
Labcorp Holdings (LH)	$22.2B
Natera (NTRA)	$19B
BioMerieux (BMXMF)	$17.7B
EUROFINS SCIENT (ERFSF)	$15.9B
ICON (ICLR)	$15.1B
CochLear (CHEOY)	$13.4B
Solventum (SOLV)	$12.9B
Medpace Holdings (MEDP)	$12.6B
Revvity (RVTY)	$12.2B
Viatris (VTRS)	$11B
Avantor (AVTR)	$9.7B
Sonic Healthcare (SKHHY)	$9.1B
Charles River Laboratories (CRL)	$8.7B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$7.5B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5.1B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.5B
Surgery Partners (SGRY)	$2.7B
Organon (OGN)	$2.7B
Concentras Parent (CON)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B